A new VKORC1 mutation leading to an isolated resistance to fluindione

British Journal of Haematology

Volumn 145, Issue 6, 2009, Pages 841-843

  Peoc'H, Katell ^a,b   Pruvot, Sandrine ^c   Gourmel, Céline ^a   Dit Sollier, Claire Bal ^b,c   Drouet, Ludovic ^a,b,c  

^a Lariboisiere Hospital   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c CREATIF

Author keywords

Oral anticoagulant; Pharmacogenomic; VKORC1

Indexed keywords

FLUINDIONE; MENADIONE EPOXIDE; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE MULTIPROTEIN COMPLEX; WARFARIN;

CLINICAL FEATURE; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MITRAL VALVE PROSTHESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTICOAGULANTS; DRUG RESISTANCE; HUMANS; MALE; MIXED FUNCTION OXYGENASES; MUTATION, MISSENSE; PHENINDIONE; WARFARIN;

EID: 66749117699     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07687.x     Document Type: Letter

References (11)

1. Aklillu, E., Leong, C., Loebstein, R., Halkin, H. Gak, E. (2008) VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals. Blood, 111, 3903 3904.
2. Bodin, L., Verstuyft, C., Tregouet, D.A., Robert, A., Dubert, L., Funck-Brentano, C., Jaillon, P., Beaune, P., Laurent-Puig, P., Becquemont, L. Loriot, M.A. (2005a) Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. Blood, 106, 135 140. (Pubitemid 40967184)
3. Bodin, L., Horellou, M.H., Flaujac, C., Loriot, M.A. Samama, M.M. (2005b) A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance. Journal of Thrombosis and Haemostasis, 3, 1533 1535. (Pubitemid 41725215)
4. Gan, G.G., Teh, A., Goh, K.Y., Chong, H.T. Pang, K.W. (2003) Racial background is a determinant factor in the maintenance dosage of warfarin. International Journal of Hematology, 78, 84 86. (Pubitemid 36899909)
5. Harrington, D.J., Underwood, S., Morse, C., Shearer, M.J., Tuddenham, E.G. Mumford, A.D. (2005) Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1. Thrombosis and Haemostasis, 93, 23 26. (Pubitemid 40124250)
6. Li, T., Chang, C.Y., Jin, D.Y., Lin, P.J., Khvorova, A. Stafford, D.W. (2004) Identification of the gene for vitamin K epoxide reductase. Nature, 427, 541 544. (Pubitemid 38209111)
7. Osman, A., Enström, C., Arbring, K., Söderkvist, P. Lindahl, T.L. (2006) Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. Journal of Thrombosis and Haemostasis, 4, 1723 1729. (Pubitemid 44144799)
8. Rieder, M.J., Reiner, A.P., Gage, B.F., Nickerson, D.A., Eby, C.S., McLeod, H.L., Blough, D.K., Thummel, K.E., Veenstra, D.L. Rettie, A.E. (2005) Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. New England Journal of Medicine, 2, 352.
9. Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hortnagel, K., Pelz, H.J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E.G., Muller, C.R., Strom, T.M. Oldenburg, J. (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature, 427, 537 541. (Pubitemid 38209110)
10. Wilms, E.B., Touw, D.J., Conemans, J.M., Veldkamp, R. Hermans, M. (2008) A new VKORC1 allelic variant (pTrp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon. Journal of Thrombosis and Haemostasis, 6, 1224 1226.
11. Yin, T. Miyata, T. (2007) Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - Rationale and perspectives. Thrombosis Research, 120, 1 10. (Pubitemid 46601582)